| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the National Multiple Sclerosis Competence Centre (N.G., S.B.G., K.-M.M.) and National Multiple Sclerosis Registry (J.H.A., R.M.), Department of Neurology (H.H.), Haukeland University Hospital, and Institute of Clinical Medicine (N.G., H.N., K.-M.M.), Department of Neurology, Haukeland University Hospital, University of Bergen, Bergen, Norway.
Address correspondence and reprint requests to N. Grytten, National Multiple Sclerosis Competence Centre, Department of Neurology, Haukeland University Hospital, N-5021 Bergen, Norway; e-mail: nina.grytten{at}helse-bergen.no
Objective: To assess longitudinal follow-up of the incidence of multiple sclerosis (MS) through five decades and estimate the prevalence rate in Hordaland County, Norway, on January 1, 2003.
Methods: All patients with MS diagnosed from 1953 to 2003 were identified in the patient records of the Department of Neurology, Haukeland University Hospital, Bergen, Norway. The diagnostic criteria of Poser et al. were applied and only patients with definite and probable MS were included. The study comprises 912 patients, and 666 patients with MS were living in Hordaland on January 1, 2003. The annual incidence rates for the years 1953 to 2003 were calculated.
Results: The total crude prevalence rate on January 1, 2003, was 150.8 per 100,000 population: 191.3 per 100,000 among women and 109.8 per 100,000 among men. The annual incidence of MS increased from 1.8 per 100,000 in 1953 to 1957 to 6.0 per 100,000 in 1993 to 1997.
Conclusions: Hordaland County, Norway, has changed from a low-risk to a high-risk area for multiple sclerosis (MS) during the last 50 years. During the last 25 years, the incidence of MS has been stable rather than increasing. Systematic longitudinal follow-up studies are essential to calculate reliable prevalence and incidence rates in MS. The results suggest that both methodologic and environmental factors are essential in determining the distribution of MS.
Supported by the Kjell Alme’s Legacy, the Norwegian Multiple Sclerosis Society, and the Bergen and Hordaland Multiple Sclerosis Society.
Disclosure: The authors report no conflicts of interest.
Received August 3, 2005. Accepted in final form October 7, 2005.
Related Article
Neurology 2006 66: 158-159.
This article has been cited by other articles:
|
|
 |
|
  N Grytten Torkildsen, S. Lie, J. Aarseth, H Nyland, and K. Myhr Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway Multiple Sclerosis, November 1, 2008; 14(9): 1191 - 1198. [Abstract] [PDF]
|
|
|
|
|
|
H Houzen, M Niino, D Hata, F Nakano, S Kikuchi, T Fukazawa, and H Sasaki Increasing prevalence and incidence of multiple sclerosis in northern Japan Multiple Sclerosis, August 1, 2008; 14(7): 887 - 892. [Abstract] [PDF]
|
|
|
|
|
|
Q Cheng, L Miao, J Zhang, Y. Guan, Z. Liu, X Wang, X. Sun, Z. Zhao, Y. Song, X. Ding, et al. Clinical features of patients with multiple sclerosis from a survey in Shanghai, China Multiple Sclerosis, June 1, 2008; 14(5): 671 - 678. [Abstract] [PDF]
|
|
|
|
 |
|
 W. J. Hader and I. M.L. Yee Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan Neurology, September 18, 2007; 69(12): 1224 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Debouverie, S. Pittion-Vouyovitch, S. Louis, T. Roederer, and F. Guillemin Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France Multiple Sclerosis, September 1, 2007; 13(8): 962 - 967. [Abstract] [PDF]
|
|
|
|
|
|
Q. Cheng, L. Miao, J. Zhang, S. -J. Ding, Z. -G. Liu, X. Wang, X. -J. Sun, Z. -X. Zhao, Y. -J. Song, X. -Y. Ding, et al. A population-based survey of multiple sclerosis in Shanghai, China Neurology, May 1, 2007; 68(18): 1495 - 1500. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
